Clinical predictors of an optimal response to natalizumab in multiple sclerosis. Sargento-Freitas J, Batista S, Macario C, Matias F, Sousa L J Clin Neurosci. 2013 Feb 25. PMID: 23485407. Abstract CommentRecommendBookmarkWatch